John Simpson

FoxHollow Technologies, Inc. designs, develops, manufactures, and sells medical devices primarily for the treatment of peripheral artery disease (PAD) and other cardiovascular disease. It offers the SilverHawk Plaque Excision System, a minimally-invasive catheter system that treats PAD by removing plaque to reopen narrowed or blocked arteries. Thecompany sells its SilverHawk Plaque Excision System through direct sales force in the United States, principally to interventional cardiologists, vascular surgeons, and interventional radiologists.